BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28301299)

  • 1. Differential role for PAK1 and PAK4 during the invadopodia lifecycle.
    Nicholas NS; Pipili A; Lesjak MS; Wells CM
    Small GTPases; 2019 Jul; 10(4):289-295. PubMed ID: 28301299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells.
    Nicholas NS; Pipili A; Lesjak MS; Ameer-Beg SM; Geh JL; Healy C; MacKenzie Ross AD; Parsons M; Nestle FO; Lacy KE; Wells CM
    Oncotarget; 2016 Oct; 7(43):70881-70897. PubMed ID: 27765920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27
    Jeannot P; Nowosad A; Perchey RT; Callot C; Bennana E; Katsube T; Mayeux P; Guillonneau F; Manenti S; Besson A
    Elife; 2017 Mar; 6():. PubMed ID: 28287395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RhoA and mTORC2/Rictor by Fingolimod (FTY720) induces p21-activated kinase 1, PAK-1 and amplifies podosomes in mouse peritoneal macrophages.
    Chen W; Ghobrial RM; Li XC; Kloc M
    Immunobiology; 2018 Nov; 223(11):634-647. PubMed ID: 30005970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
    Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
    Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly.
    Moshfegh Y; Bravo-Cordero JJ; Miskolci V; Condeelis J; Hodgson L
    Nat Cell Biol; 2014 Jun; 16(6):574-86. PubMed ID: 24859002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
    PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.
    Wells CM; Whale AD; Parsons M; Masters JR; Jones GE
    J Cell Sci; 2010 May; 123(Pt 10):1663-73. PubMed ID: 20406887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAK4 and alphaPIX determine podosome size and number in macrophages through localized actin regulation.
    Gringel A; Walz D; Rosenberger G; Minden A; Kutsche K; Kopp P; Linder S
    J Cell Physiol; 2006 Nov; 209(2):568-79. PubMed ID: 16897755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.
    Williams KC; Cepeda MA; Javed S; Searle K; Parkins KM; Makela AV; Hamilton AM; Soukhtehzari S; Kim Y; Tuck AB; Ronald JA; Foster PJ; Chambers AF; Leong HS
    Oncogene; 2019 May; 38(19):3598-3615. PubMed ID: 30651600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin.
    Dan C; Kelly A; Bernard O; Minden A
    J Biol Chem; 2001 Aug; 276(34):32115-21. PubMed ID: 11413130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P21-activated kinase 4--not just one of the PAK.
    Dart AE; Wells CM
    Eur J Cell Biol; 2013; 92(4-5):129-38. PubMed ID: 23642861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC42 binds PAK4 via an extended GTPase-effector interface.
    Ha BH; Boggon TJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):531-536. PubMed ID: 29295922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIT1/βPIX signaling proteins and PAK1 kinase regulate microtubule nucleation.
    Černohorská M; Sulimenko V; Hájková Z; Sulimenko T; Sládková V; Vinopal S; Dráberová E; Dráber P
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1282-97. PubMed ID: 27012601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
    Foxall E; Staszowska A; Hirvonen LM; Georgouli M; Ciccioli M; Rimmer A; Williams L; Calle Y; Sanz-Moreno V; Cox S; Jones GE; Wells CM
    Cell Rep; 2019 Dec; 29(11):3385-3393.e6. PubMed ID: 31825823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
    Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
    J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel PAK1 variant causative of neurodevelopmental disorder with postnatal macrocephaly.
    Ohori S; Mitsuhashi S; Ben-Haim R; Heyman E; Sengoku T; Ogata K; Matsumoto N
    J Hum Genet; 2020 May; 65(5):481-485. PubMed ID: 32005903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.